The Severity of Skin Manifestations in Women who have Clinical Androgen Excess with and without Polycystic Ovarian Morphology by Ultrasonography

Not Applicable

• Conditions: Polycystic ovary syndromeAndrogen excess; Skin manifestations; Polycystic ovary syndrome; Androgen excess; Acne vulgaris; Androgenic alopecia; Hirsutism; Seborrhea; SAHA; HAIR&#45

• Registration Number: TCTR20180920007
• Lead Sponsor: Ratchadapiseksompotch Fund, Faculty of Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2018-09-20
• Study Completion: 2018-12-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: Female
• Target Recruitment: 100

Inclusion Criteria

Women
age between 18-40 years old
Having Clinical Androgen Excess at least 2 symptoms (acne, seborrhea, hirsutism, androgenetic alopecia)

Exclusion Criteria

pregnancy
History of hormonal therapy within 3 months or steroid treatment within 6 months
History of receiving hair removal lasers within 6 months or hair wax within 1 month or shaving within 1 week
History of receiving topical minoxidil or oral finasteride within 6 months

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
acne severity on recruiting day physical examination

Secondary Outcome Measures

Name	Time	Method
hirsutism severity on recruiting day physical examination,seborrhea on recruiting day questionnaire